delorazepam Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Delorazepam, also known as chlordesmethyldiazepam and nordiclazepam, is a drug which is a benzodiazepine and a derivative of desmethyldiazepam. It is marketed in Italy, where it is available under the trade name EN and Dadumir. Delorazepam (chlordesmethyldiazepam) is also an active metabolite of the benzodiazepine drugs diclazepam and cloxazolam. Adverse effects may include hangover type effects, drowsiness, behavioural impairments and short-term memory impairments. Similar to other benzodiazepines delorazepam has anxiolytic, skeletal muscle relaxant, hypnotic and anticonvulsant properties.   Wikipedia

Chemistry

  • SMILES: O=C1CN=C(c2ccccc2Cl)c2cc(Cl)ccc2N1
  • InChIKey: CHIFCDOIPRCHCF-UHFFFAOYSA-N
  • Mol. Mass: 305.16
  • ALogP: 3.78
  • ChEMBL Molecule:
    delorazepam  
More Chemistry

Pharmacology

Alternative names

2'-chloronordiazepam | 2h-1,4-benzodiazepin-2-one, 7-chloro-5-(2-chlorophenyl)-1,3-dihydro- | 7-chloro-5-(2-chlorophenyl) 1,3-dihydro-2h-1,4-benzodiazepin-2-one | cddz | chlordemethyldiazepam | chlordesmethyldiazepam | chlorodesmethyldiazepam | dadumir | delorazepam

Organizations (2)

Research & Development (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Overview

  • Highest Phase: N/A
  • # of Trials: 1
  • # of Trial Organizations: 2

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue